Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 386, Issue 12, pp 1081–1093 | Cite as

Accumulation of serum lipids by vascular smooth muscle cells involves a macropinocytosis-like uptake pathway and is associated with the downregulation of the ATP-binding cassette transporter A1

  • Jennifer Rivera
  • Anna K. Walduck
  • Shane R. Thomas
  • Elias N. Glaros
  • Elizabeth U. Hooker
  • Elizabeth Guida
  • Christopher G. SobeyEmail author
  • Grant R. Drummond
Original Article

Abstract

Vascular smooth muscle cells (VSMC) are present in arterial intima before atherosclerotic plaques develop and are likely to be exposed to unmodified serum lipids as they enter the vessel wall. We examined the effects of sera from mice on the morphology and function of mouse VSMC. Incubation of a mouse VSMC line (MOVAS) with sera from normocholesterolemic (C57BL/6J) or hypercholesterolemic (APOE−/−) mice caused concentration-dependent increases in lipid accumulation as measured by AdipoRed, with the extent of lipid uptake significantly greater with the latter sera type. Inhibition of c-Jun N-terminal kinases (SP600125), Src kinases (AG1879), and clathrin-dependent endocytosis (monodansylcadaverine) to disrupt scavenger receptor-mediated uptake of lipids had no effect on serum-induced lipid accumulation by VSMC. By contrast, inhibition of macropinocytosis with antagonists of PI-3 kinase (LY294002) and actin (cytochalasin D) markedly reduced lipid accumulation. Serum exposure reduced the expression of the ATP-binding cassette transporter A1, consistent with impaired cholesterol efflux, but had no effect on the expression of markers of VSMC differentiation. Moreover, the expression of several inflammation and foam cell markers was unchanged (CCL2, CCL5, and CD68) by mouse sera. The accumulation of unmodified serum lipids by VSMC involves a macropinocytosis-like uptake pathway and is associated with the downregulation of the ATP-binding cassette transporter. We speculate that VSMC may play an atheroprotective role in arterial intima by acting as a “sink” for unmodified lipids.

Keywords

Serum lipids Vascular smooth muscle cells Foam cells Macropinocytosis ATP-binding cassette transporter A1 

Notes

Acknowledgments

The authors would like to thank Mr. Stephen Firth for his expertise and assistance in acquiring the time-lapse videos of the VSMC. This work was supported by research grants from the National Health and Medical Research Council of Australia (NHMRC; ID nos. 545942 and 436825). JR was supported by a scholarship from the Monash University Faculty of Medicine, Nursing and Health Sciences, while GRD and CGS were supported by fellowships from the NHMRC (ID nos. APP1006017 and 350327, respectively).

Supplementary material

ESM 1

(AVI 35917 kb)

ESM 2

(AVI 35881 kb)

ESM 3

(AVI 35917 kb)

References

  1. Afroze T, Yang LL, Wang C, Gros R, Kalair W, Hoque AN, Mungrue IN, Zhu Z, Husain M (2003) Calcineurin-independent regulation of plasma membrane Ca2+ ATPase-4 in the vascular smooth muscle cell cycle. Am J Physiol Cell Physiol 285:C88–C95PubMedCrossRefGoogle Scholar
  2. Anton IM, Saville SP, Byrne MJ, Curcio C, Ramesh N, Hartwig JH, Geha RS (2003) WIP participates in actin reorganization and ruffle formation induced by PDGF. J Cell Sci 116:2443–2451PubMedCrossRefGoogle Scholar
  3. Araki N, Johnson MT, Swanson JA (1996) A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 135:1249–1260PubMedCrossRefGoogle Scholar
  4. Barlic J, Zhang Y, Murphy PM (2007) Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha–NFkappaB-dependent manner. J Biol Chem 282:19167–19176PubMedCrossRefGoogle Scholar
  5. Bobryshev YV (2006) Monocyte recruitment and foam cell formation in atherosclerosis. Micron 37:208–222PubMedCrossRefGoogle Scholar
  6. Bryant DM, Kerr MC, Hammond LA, Joseph SR, Mostov KE, Teasdale RD, Stow JL (2007) EGF induces macropinocytosis and SNX1-modulated recycling of E-cadherin. J Cell Sci 120:1818–1828PubMedCrossRefGoogle Scholar
  7. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G (1998) Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 139:205–222PubMedCrossRefGoogle Scholar
  8. Chait A, Wight TN (2000) Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol 11:457–463PubMedCrossRefGoogle Scholar
  9. Chen L, Yang G, Zhang X, Wu J, Gu Q, Wei M, Yang J, Zhu Y, Wang N, Guan Y (2009) Induction of MIF expression by oxidized LDL via activation of NF-kappaB in vascular smooth muscle cells. Atherosclerosis 207:428–433PubMedCrossRefGoogle Scholar
  10. Choi HY, Rahmani M, Wong BW, Allahverdian S, McManus BM, Pickering JG, Chan T, Francis GA (2009a) ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circulation 119:3223–3231PubMedCrossRefGoogle Scholar
  11. Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, Witztum JL, Bae YS, Miller YI (2009b) Lipoprotein accumulation in macrophages via Toll-like receptor-4-dependent fluid phase uptake. Circ Res 104:1355–1363PubMedCrossRefGoogle Scholar
  12. Coller SP, Paulnock DM (2001) Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J Leukoc Biol 70:142–148PubMedGoogle Scholar
  13. de Graaf R, Kloppenburg G, Kitslaar PJ, Bruggeman CA, Stassen F (2006) Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 8:1859–1865PubMedCrossRefGoogle Scholar
  14. Floren CH, Albers JJ, Bierman EL (1981) Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochim Biophys Acta 663:336–349PubMedCrossRefGoogle Scholar
  15. Garcia-Perez BE, Hernandez-Gonzalez JC, Garcia-Nieto S, Luna-Herrera J (2008) Internalization of a non-pathogenic mycobacteria by macropinocytosis in human alveolar epithelial A549 cells. Microb Pathog 45:1–6PubMedCrossRefGoogle Scholar
  16. Goldfischer S, Schiller B, Wolinsky H (1975) Lipid accumulation in smooth muscle cell lysosomes in primate atherosclerosis. Am J Pathol 78:497–504PubMedGoogle Scholar
  17. Ishii I, Satoh H, Kawachi H, Jingami H, Matsuoka N, Ohmori S, Bujo H, Yamamoto T, Saito Y, Kitada M (2002) Intimal smooth muscle cells up-regulate beta-very low density lipoprotein-mediated cholesterol accumulation by enhancing beta-very low density lipoprotein uptake and decreasing cholesterol efflux. Biochim Biophys Acta 1585:30–38PubMedCrossRefGoogle Scholar
  18. Jones NL, Willingham MC (1999) Modified LDLs are internalized by macrophages in part via macropinocytosis. Anat Rec 255:57–68PubMedCrossRefGoogle Scholar
  19. Kerr MC, Teasdale RD (2009) Defining macropinocytosis. Traffic 10:364–371PubMedCrossRefGoogle Scholar
  20. Klouche M, Rose-John S, Schmiedt W, Bhakdi S (2000) Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 101:1799–1805PubMedCrossRefGoogle Scholar
  21. Kruth HS, Jones NL, Huang W, Zhao B, Ishii I, Chang J, Combs CA, Malide D, Zhang WY (2005) Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem 280:2352–2360PubMedCrossRefGoogle Scholar
  22. Li H, Freeman MW, Libby P (1995) Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 95:122–133PubMedCrossRefGoogle Scholar
  23. Lim HJ, Lee S, Lee KS, Park JH, Jang Y, Lee EJ, Park HY (2006) PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs. Prostaglandins Other Lipid Mediat 80:165–174PubMedCrossRefGoogle Scholar
  24. Martinez-Argudo I, Jepson MA (2008) Salmonella translocates across an in vitro M cell model independently of SPI-1 and SPI-2. Microbiology 154:3887–3894PubMedCrossRefGoogle Scholar
  25. Matsumoto K, Hirano K, Nozaki S, Takamoto A, Nishida M, Nakagawa-Toyama Y, Janabi MY, Ohya T, Yamashita S, Matsuzawa Y (2000) Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis. Arterioscler Thromb Vasc Biol 20:1027–1032PubMedCrossRefGoogle Scholar
  26. Nakashima Y, Chen YX, Kinukawa N, Sueishi K (2002) Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age. Virchows Arch 441:279–288PubMedCrossRefGoogle Scholar
  27. Nakashima Y, Wight TN, Sueishi K (2008) Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc Res 79:14–23PubMedCrossRefGoogle Scholar
  28. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL (2006) A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4:211–221PubMedCrossRefGoogle Scholar
  29. Restrepo C, Strong JP, Guzman MA, Tejada C (1979) Geographic comparisons of diffuse intimal thickening of the aorta. Atherosclerosis 32:177–193PubMedCrossRefGoogle Scholar
  30. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, Hersberger M, Eriksson U, Eberli FR, Becher B, Boren J, Chen M, Cybulsky MI, Moore KJ, Freeman MW, Wagner EF, Matter CM, Luscher TF (2004) Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 306:1558–1561PubMedCrossRefGoogle Scholar
  31. Rivera J, Walduck AK, Strugnell RA, Sobey CG, Drummond GR (2012) Chlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species. Clin Exp Pharmacol Physiol 39:218–226PubMedCrossRefGoogle Scholar
  32. Rong JX, Shapiro M, Trogan E, Fisher EA (2003) Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci U S A 100:13531–13536PubMedCrossRefGoogle Scholar
  33. Ruan XZ, Moorhead JF, Tao JL, Ma KL, Wheeler DC, Powis SH, Varghese Z (2006) Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 26:1150–1155PubMedCrossRefGoogle Scholar
  34. Silverstein RL, Li W, Park YM, Rahaman SO (2010) Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. Trans Am Clin Climatol Assoc 121:206–220PubMedGoogle Scholar
  35. Sima AV, Botez GM, Stancu CS, Manea A, Raicu M, Simionescu M (2010) Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress. J Cell Mol Med 14:2790–2802PubMedCrossRefGoogle Scholar
  36. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD et al (1992) A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 12:120–134PubMedCrossRefGoogle Scholar
  37. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 14:840–856PubMedCrossRefGoogle Scholar
  38. Sun Y, Chen X (2010) Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species. Fundam Clin Pharmacol 25:572–579Google Scholar
  39. Tabas I, Williams KJ, Boren J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:1832–1844PubMedCrossRefGoogle Scholar
  40. Takebayashi S, Kubota I, Kamio A, Takagi T (1972) Ultrastructural aspects of human atherosclerosis; role of the foam cells and modified smooth muscle cells. J Electron Microsc (Tokyo) 21:301–313Google Scholar
  41. Wagsater D, Olofsson PS, Norgren L, Stenberg B, Sirsjo A (2004) The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. Biochem Biophys Res Commun 325:1187–1193PubMedCrossRefGoogle Scholar
  42. Webb NR, Moore KJ (2007) Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy. Curr Drug Targets 8:1249–1263PubMedCrossRefGoogle Scholar
  43. Williams KJ, Tabas I (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551–561PubMedCrossRefGoogle Scholar
  44. Yao W, Li K, Liao K (2009) Macropinocytosis contributes to the macrophage foam cell formation in RAW264.7 cells. Acta Biochim Biophys Sin (Shanghai) 41:773–780CrossRefGoogle Scholar
  45. Yvan-Charvet L, Wang N, Tall AR (2010) Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 30:139–143PubMedCrossRefGoogle Scholar
  46. Zhao Y, Mangalmurti NS, Xiong Z, Prakash B, Guo F, Stolz DB, Lee JS (2011) Duffy antigen receptor for chemokines mediates chemokine endocytosis through a macropinocytosis-like process in endothelial cells. PLoS One 6:e29624PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Jennifer Rivera
    • 1
    • 2
  • Anna K. Walduck
    • 2
  • Shane R. Thomas
    • 3
  • Elias N. Glaros
    • 3
  • Elizabeth U. Hooker
    • 1
  • Elizabeth Guida
    • 1
  • Christopher G. Sobey
    • 1
    Email author
  • Grant R. Drummond
    • 1
  1. 1.Vascular Biology and Immunopharmacology Group, Department of PharmacologyMonash UniversityClaytonAustralia
  2. 2.Department of Microbiology and ImmunologyThe University of MelbourneParkvilleAustralia
  3. 3.Centre for Vascular Research, School of Medical SciencesUniversity of New South WalesSydneyAustralia

Personalised recommendations